Pharmarama, a leader in the procurement of pharmaceutical products for comparator trials and named patient programs, today announced the launch of its new corporate Website at www.pharmarama.com.
BOSTON (Business Wire EON) January 8, 2008 --
Pharmarama, a leader in the
procurement of pharmaceutical products for comparator
trials and named
patient programs, today announced the launch of its new corporate
Website at www.pharmarama.com.
The new Website coincides with the establishment of Pharmarama’s
U.S. sales and marketing office in Boston and highlights the firm’s
capabilities in the growing fields of comparator
drug sourcing for clinical trials and providing drugs for named
patient programs worldwide. The company maintains its headquarters
in London, England and has additional offices in Germany.
“We are in such a dynamic business that we
needed to have a site that provided our clients and prospects with
easily accessible information about our company and its capabilities,”
said Tammy
Bishop, Pharmarama’s vice president of
U.S. business development. “This new site will
also serve as an interactive communication medium with our clients,
keeping them up to date on the latest developments in the field and
providing useful links to industry resources.”
Pharmarama was founded
in 2006 by Ben
Rabin as the U.S. affiliate of U.K.-based BR
Pharma Limited, which first gained recognition for obtaining
regulatory permission to import Ritalin SR into the U.K. Rabin, a
pharmacist with over 40 years in the retail and wholesale pharmaceutical
industries, and BR Pharma have provided over a decade of service to the
world’s leading pharmaceutical companies and
clinical research organizations sourcing and procuring pharmaceutical
products for clinical trials, as well as providing services for named
patient programs. Pharmarama works in collaboration with BR Pharma as a
single point of contact for the sourcing, repacking, blinding and
distribution of comparator drugs worldwide.
“We strived to create a site that would
emphasize the key characteristics of the company - including its
extensive track record, consultative approach to service and decades of
experience in the supply of medicines worldwide,”
said Marcia Polese, principal of the integrated marketing firm Polese
Clancy, which developed the site. “We
focused on the terms reliability, flexibility and know-how to
characterize the key differentiators of the firm and deployed navigation
that highlights Pharmarama's named patient and comparator drug services.”
Pharmarama’s named
patient programs allow for the supply and use of unlicensed
medicines under strictly limited conditions to meet the special needs of
a particular patient where a licensed equivalent does not exist. Named
patient medicines include medicines that are not yet licensed in a
territory, as well as investigational drugs awaiting approval.
Pharmarama works with leading pharmaceutical companies in establishing
formally structured named patient programs in the pre-launch phase of a
medicine’s lifecycle.
Comparator drugs are used in clinical trials to compare therapies under
review to current therapies commercially available in the market. An
estimated 20 percent of all clinical pharmaceutical studies globally use
comparator products. Pharmarama provides validated
comparator drug services – with speed,
accuracy and the highest degree of ethical standards –
to the world’s leading pharmaceutical
companies and clinical research organizations.
About Pharmarama
Pharmarama is a
licensed wholesaler and importer of licensed and unlicensed medicines,
based in London, England, with offices located in the United States and
Germany. The company, in partnership with BR
Pharma Limited, provides validated comparator drug services such as
sourcing, supply chain management and support services, including drug
warehousing, custom pharmaceutical manufacturing, packing and
translation services.
For more information, please visit us on the Web at www.pharmarama.com
or www.brpharmaltd.co.uk.
Trackback URL: http://www.prweb.com/pingpr.php/RmFsdS1TaW5nLUNyYXMtU3F1YS1Mb3ZlLVplcm8=
|
